Glucocorticoid and its effect on cardiac glucose utilization

Glycogen is an immediate source of glucose for cardiac tissue to maintain its metabolic homeostasis. However, its excess brings about cardiac structural and physiological impairments. Previously, we have demonstrated that in hearts from dexamethasone (DEX) treated animals, glycogen accumulation was...

Full description

Bibliographic Details
Main Author: Puthanveetil, Prasanth Nair
Format: Others
Language:English
Published: University of British Columbia 2009
Subjects:
Online Access:http://hdl.handle.net/2429/5038
id ndltd-UBC-oai-circle.library.ubc.ca-2429-5038
record_format oai_dc
spelling ndltd-UBC-oai-circle.library.ubc.ca-2429-50382018-01-05T17:23:16Z Glucocorticoid and its effect on cardiac glucose utilization Puthanveetil, Prasanth Nair AMPK Glycogen Glycogen is an immediate source of glucose for cardiac tissue to maintain its metabolic homeostasis. However, its excess brings about cardiac structural and physiological impairments. Previously, we have demonstrated that in hearts from dexamethasone (DEX) treated animals, glycogen accumulation was enhanced. We examined the influence of DEX on glucose entry and glycogen synthase as a means of regulating the accumulation of this stored polysaccharide. Following DEX, cardiac tissue had limited contribution towards the development of whole body insulin resistance. Measurement of GLUT4 at the plasma membrane revealed an excess presence of this transporter protein at this location. Interestingly, this was accompanied by an increase in GLUT4 in the intracellular membrane fraction, an effect that was well correlated to an increased GLUT4 mR.NA. Both total and phosphorylated AMPK increased following DEX. Immunoprecipitation of AS 160 followed by Western blotting demonstrated no change in Akt phosphorylation at Ser473 and Thr308 in DEX treated hearts. However, there was a significant increase in AMPK phosphorylation at Thr172, which correlated well with AS 160 phosphorylation. In DEX hearts, there was a considerable reduction in the phosphorylation of glycogen synthase, whereas GSK-3-β phosphorylation was augmented. Our data suggest that AMPK mediated glucose entry, combined with activation of glycogen synthase and reduction in glucose oxidation (Qi, D., et al. Diabetes 53:1790, 2004), act together to promote glycogen storage. Our data suggest that in the presence of intact insulin signaling, AMPK mediated glucose entry, combined with activation of glycogen synthase and the previously reported reduction in glucose oxidation, act together to promote glycogen storage. Should these effects persist chronically, they may explain the increased morbidity and mortality observed with long term excesses in endogenous or exogenous glucocorticoids. Pharmaceutical Sciences, Faculty of Graduate 2009-02-25T18:34:29Z 2009-02-25T18:34:29Z 2008 2008-11 Text Thesis/Dissertation http://hdl.handle.net/2429/5038 eng Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ 1393576 bytes application/pdf University of British Columbia
collection NDLTD
language English
format Others
sources NDLTD
topic AMPK
Glycogen
spellingShingle AMPK
Glycogen
Puthanveetil, Prasanth Nair
Glucocorticoid and its effect on cardiac glucose utilization
description Glycogen is an immediate source of glucose for cardiac tissue to maintain its metabolic homeostasis. However, its excess brings about cardiac structural and physiological impairments. Previously, we have demonstrated that in hearts from dexamethasone (DEX) treated animals, glycogen accumulation was enhanced. We examined the influence of DEX on glucose entry and glycogen synthase as a means of regulating the accumulation of this stored polysaccharide. Following DEX, cardiac tissue had limited contribution towards the development of whole body insulin resistance. Measurement of GLUT4 at the plasma membrane revealed an excess presence of this transporter protein at this location. Interestingly, this was accompanied by an increase in GLUT4 in the intracellular membrane fraction, an effect that was well correlated to an increased GLUT4 mR.NA. Both total and phosphorylated AMPK increased following DEX. Immunoprecipitation of AS 160 followed by Western blotting demonstrated no change in Akt phosphorylation at Ser473 and Thr308 in DEX treated hearts. However, there was a significant increase in AMPK phosphorylation at Thr172, which correlated well with AS 160 phosphorylation. In DEX hearts, there was a considerable reduction in the phosphorylation of glycogen synthase, whereas GSK-3-β phosphorylation was augmented. Our data suggest that AMPK mediated glucose entry, combined with activation of glycogen synthase and reduction in glucose oxidation (Qi, D., et al. Diabetes 53:1790, 2004), act together to promote glycogen storage. Our data suggest that in the presence of intact insulin signaling, AMPK mediated glucose entry, combined with activation of glycogen synthase and the previously reported reduction in glucose oxidation, act together to promote glycogen storage. Should these effects persist chronically, they may explain the increased morbidity and mortality observed with long term excesses in endogenous or exogenous glucocorticoids. === Pharmaceutical Sciences, Faculty of === Graduate
author Puthanveetil, Prasanth Nair
author_facet Puthanveetil, Prasanth Nair
author_sort Puthanveetil, Prasanth Nair
title Glucocorticoid and its effect on cardiac glucose utilization
title_short Glucocorticoid and its effect on cardiac glucose utilization
title_full Glucocorticoid and its effect on cardiac glucose utilization
title_fullStr Glucocorticoid and its effect on cardiac glucose utilization
title_full_unstemmed Glucocorticoid and its effect on cardiac glucose utilization
title_sort glucocorticoid and its effect on cardiac glucose utilization
publisher University of British Columbia
publishDate 2009
url http://hdl.handle.net/2429/5038
work_keys_str_mv AT puthanveetilprasanthnair glucocorticoidanditseffectoncardiacglucoseutilization
_version_ 1718581916550037504